https://www.selleckchem.com/pr....oducts/lusutrombopag
3%). The median PFS and OS were found to be significantly shorter in M-spike cohort 1 compared with their counterparts (median PFS, 10 months versus 26 months [P less then .0001]; median OS, 35 months versus 79 months [P less then .0001]). An increase in involved FLC by at least 5 mg/dL was observed in 25 patients (2.3%). Similarly, the median PFS and OS were found to be inferior in FLC cohort 1 compared with FLC cohort 2 (median PFS, 4 months versus 28 months [P less then .0001]; median OS, 11 months versus 82 months [P less then
Curtir
Comentario
Compartilhar
